Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Larkina

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Molecular Pharmaceutics|April 1, 2024
Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins <i>G3</i> for the <sup>99m</sup>Tc-Based Imaging of HER2-Expressing Malignant TumorsMaria Larkina, Ruslan Varvashenya, Feruza Yuldasheva, et al.
Cancers|July 24, 2021
Influence of the Position and Composition of Radiometals and Radioiodine Labels on Imaging of Epcam Expression in Prostate Cancer Model Using the DARPin Ec1Sergey M Deyev, Tianqi Xu, Yongsheng Liu, et al.
Kidney International|July 31, 2014
Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortalityGeorge R Bailie, Maria Larkina, David A Goodkin, et al.
Pharmaceutics|October 29, 2025
Phase I Clinical Study with the GRPR-Antagonist [<sup>99m</sup>Tc]Tc-DB8 for SPECT Imaging of Prostate Cancer: Does the Injected Peptide Mass Make a Difference?Anna Orlova, Anastasia Rybina, Anna Medvedeva, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 1, 2013
Variation in intravenous iron use internationally and over time: the Dialysis Outcomes and Practice Patterns Study (DOPPS)George R Bailie, Maria Larkina, David A Goodkin, et al.
Kidney International|May 17, 2013
Major bleeding events and risk stratification of antithrombotic agents in hemodialysis: results from the DOPPSManish M Sood, Maria Larkina, Jyothi R Thumma, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 2, 2024
Half-life extension via ABD-fusion leads to higher tumor uptake of an affibody-drug conjugate compared to PAS- and XTENylationJie Zhang, Vitalina Bodenko, Maria Larkina, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 20, 2017
International Comparisons of Prevalence, Awareness, and Treatment of Pruritus in People on HemodialysisHugh C Rayner, Maria Larkina, Mia Wang, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 2, 2020
International variation in dialysis discontinuation in patients with advanced kidney diseaseSarbjit V Jassal, Maria Larkina, Kitty J Jager, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 28, 2018
Missed Hemodialysis Treatments: International Variation, Predictors, and Outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS)Issa Al Salmi, Maria Larkina, Mia Wang, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Molecular Pharmaceutics|April 1, 2024
Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins <i>G3</i> for the <sup>99m</sup>Tc-Based Imaging of HER2-Expressing Malignant TumorsMaria Larkina, Ruslan Varvashenya, Feruza Yuldasheva, et al.
Cancers|July 24, 2021
Influence of the Position and Composition of Radiometals and Radioiodine Labels on Imaging of Epcam Expression in Prostate Cancer Model Using the DARPin Ec1Sergey M Deyev, Tianqi Xu, Yongsheng Liu, et al.
Kidney International|July 31, 2014
Data from the Dialysis Outcomes and Practice Patterns Study validate an association between high intravenous iron doses and mortalityGeorge R Bailie, Maria Larkina, David A Goodkin, et al.
Pharmaceutics|October 29, 2025
Phase I Clinical Study with the GRPR-Antagonist [<sup>99m</sup>Tc]Tc-DB8 for SPECT Imaging of Prostate Cancer: Does the Injected Peptide Mass Make a Difference?Anna Orlova, Anastasia Rybina, Anna Medvedeva, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 1, 2013
Variation in intravenous iron use internationally and over time: the Dialysis Outcomes and Practice Patterns Study (DOPPS)George R Bailie, Maria Larkina, David A Goodkin, et al.
Kidney International|May 17, 2013
Major bleeding events and risk stratification of antithrombotic agents in hemodialysis: results from the DOPPSManish M Sood, Maria Larkina, Jyothi R Thumma, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 2, 2024
Half-life extension via ABD-fusion leads to higher tumor uptake of an affibody-drug conjugate compared to PAS- and XTENylationJie Zhang, Vitalina Bodenko, Maria Larkina, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 20, 2017
International Comparisons of Prevalence, Awareness, and Treatment of Pruritus in People on HemodialysisHugh C Rayner, Maria Larkina, Mia Wang, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 2, 2020
International variation in dialysis discontinuation in patients with advanced kidney diseaseSarbjit V Jassal, Maria Larkina, Kitty J Jager, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|August 28, 2018
Missed Hemodialysis Treatments: International Variation, Predictors, and Outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS)Issa Al Salmi, Maria Larkina, Mia Wang, et al.
Pageof 3